Safety: Clinical Trials

5 trials for Safety, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 terminated. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Terminated 5
Phase 21Terminated 1

Follow Safety: new trials by email Literature Review of Safety trials Research Report on Safety

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Single and Multiple Intravenous Administrations of Estetrol (E4) in Healthy Adult Volunteers
single E4 28.3 mg, single E4 94.4 mg, multiple E4 94.4 mg - Safety, Pharmacokinetics
Phase 1TerminatedNEURALIS s.a.82022-04-192025-07-04
Single and Multiple Dose Escalation Trial of an Intravenous Antibiotic RC-01
Single intravenous doses of RC-01, Single intravenous doses of placebo, Multiple intravenous doses of RC-01 - Safety
Phase 1TerminatedRecida Therapeutics, Inc.82019-04-142019-05-29
TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms
MDG1011, Investigator Choice therapy - Safety, Tolerability
Phase 1 / Phase 2TerminatedMedigene AG92018-03-272023-02-15
First in Human Single Ascending Dose Study of MOR107
MOR107, Placebo, Low sodium diet - Safety
Phase 1TerminatedAlan Richardson242017-02-162018-02-07
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants
MLN3126, MLN3126 Matched Placebo - Safety, Tolerability
Phase 1TerminatedTakeda232014-07-012016-07-25

Interventions

Diet, Sodium-Restricted (1)

Sponsors

Alan Richardson (1)  ·  Medigene AG (1)  ·  NEURALIS s.a. (1)  ·  Recida Therapeutics, Inc. (1)  ·  Takeda (1)

Countries

United States (2)  ·  Bulgaria (1)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Axel Mescheder, MD (1)  ·  Simone Thomas, PD Dr. med. (1)

Results publications

PMID 39858024